TXUG - ETF AI Analysis

Top Page

Thornburg International Growth Fund ETF (TXUG)

Rating:63Neutral

Price Target:―

TXUG, the Thornburg International Growth Fund ETF, has a solid overall rating driven mainly by high-quality growth companies like ASML, AstraZeneca, Mercadolibre, and Mastercard, all of which show strong financial performance and generally supportive earnings and technical trends. Some holdings such as Air Liquide, Ferrari, and Lonza face headwinds from high valuations and periods of bearish technical momentum, which weigh on the fund’s rating. The main risk factor is that many of its key positions are richly valued growth stocks, so the ETF is sensitive to market pullbacks in expensive, growth-oriented names.

Positive Factors

Strong Lead Holding

The largest position, ASML Holding, has shown strong gains this year, giving the fund a helpful performance boost.

Broad International Diversification

The ETF spreads its investments across several countries in Europe, Asia, and the Americas, reducing reliance on any single market.

Growth-Oriented Sector Mix

Heavy exposure to technology and health care positions the fund to benefit if growth-focused sectors continue to do well.

Negative Factors

High Expense Ratio

The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns compared with lower-cost options.

Mixed Performance Among Top Holdings

Several major positions, including AstraZeneca, Nomura Research Institute, Air Liquide, and Ferrari, have shown weak or negative performance this year, which can drag on overall results.

Small Asset Base

The ETF manages a relatively low level of assets, which can sometimes lead to wider trading spreads and a higher risk the fund could be closed in the future.

TXUG vs. SPDR S&P 500 ETF (SPY)

AUM4.91M

RegionDeveloped Markets

Expense Ratio0.70%

Beta0.86

IssuerThornburg

Inception DateJan 22, 2025

Dividend Yield0.51%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume197

30 Day Avg. Volume524

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

28.87

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering43

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

TXUG Summary

TXUG, the Thornburg International Growth Fund ETF, is an actively managed fund that looks for fast-growing companies outside the U.S. (though it still holds some U.S. stocks). It doesn’t track a set index, but instead focuses on international growth stocks across many sectors, especially technology and health care. Well-known holdings include ASML Holding and Ferrari. Someone might invest in TXUG to seek long-term growth and diversify beyond the U.S. market. A key risk is that growth and foreign stocks can be more volatile, so the share price can rise and fall sharply over time.

How much will it cost me?The Thornburg International Growth Fund ETF (TXUG) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because it is actively managed, meaning professionals are selecting stocks to try to outperform the market. Active management typically results in higher costs compared to passively managed ETFs that track an index.

What would affect this ETF?The Thornburg International Growth Fund ETF (TXUG) could benefit from positive trends in technology and healthcare innovation, as these sectors make up a significant portion of its holdings. However, it may face challenges if global economic conditions worsen or if regulatory changes impact international markets, particularly in developed regions outside the U.S. Additionally, fluctuations in currency exchange rates could affect the performance of its non-U.S. investments.

TXUG Top 10 Holdings

TXUG leans heavily into international growth stories, with European and Japanese names setting the tone. ASML is one of the main engines, rising steadily and giving the fund a strong tech backbone, while HOYA adds another layer of stable, tech-driven growth from Japan. On the flip side, Ferrari has been losing speed lately, and Air Liquide’s recent slide has also weighed on returns. Healthcare is a key pillar too: AstraZeneca and Lonza are more mixed, sometimes helping, sometimes just treading water, leaving overall performance driven by a handful of big non-U.S. growth leaders.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	6.35%	$311.80K	€435.69B	61.23%	76 Outperform
7741	HOYA	5.53%	$271.76K	¥9.26T	38.43%	74 Outperform
AZN	AstraZeneca	5.06%	$248.55K	£213.91B	18.62%	80 Outperform
MELI	Mercadolibre	3.77%	$185.16K	$104.07B	3.93%	77 Outperform
AI	Air Liquide	3.70%	$182.05K	€97.46B	0.64%	66 Neutral
RACE	Ferrari	3.35%	$164.37K	$80.65B	-26.48%	72 Outperform
MA	Mastercard	3.28%	$161.15K	$497.20B	-2.69%	75 Outperform
LONN	Lonza Group Ltd	3.19%	$156.68K	CHF35.94B	-14.19%	71 Outperform
RR	Rolls-Royce Holdings	3.09%	$151.88K	£102.67B	119.88%	71 Outperform
SE	Sea	3.00%	$147.33K	$62.91B	-13.66%	69 Neutral

TXUG Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

24.77

Negative

100DMA

24.95

Negative

200DMA

25.13

Negative

Market Momentum

MACD

<0.01

Positive

RSI

37.72

Neutral

STOCH

36.17

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TXUG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 25.38, equal to the 50-day MA of 24.77, and equal to the 200-day MA of 25.13, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 37.72 is Neutral, neither overbought nor oversold. The STOCH value of 36.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TXUG.

TXUG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
TXUG	―	―	$4.91M	0.70%	―
DFIV	―	―	$17.56B	0.27%	―
DFAI	―	―	$14.11B	0.18%	―
BCIL	―	―	$76.29M	0.80%	―
INEQ	―	―	$54.38M	0.45%	―
FFDI	―	―	$15.70M	0.55%	―

Performance Comparison

TXUG

Thornburg International Growth Fund ETF

24.43

-1.17

-4.57%

DFIV

Dimensional International Value ETF

―

DFAI

Dimensional International Core Equity Market ETF

―

BCIL

Bancreek International Large Cap ETF

―

INEQ

Columbia International Equity Income Etf

―

FFDI

Fidelity Fundamental Developed International ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents